Judgment of the Court of 9 July 1997.

Generics BV v Smith Kline & French Laboratories Ltd.

Reference for a preliminary ruling: Hoge Raad - Netherlands.

Articles 30 and 36 of the EC Treaty - Patent - Registration of medicinal products - Infringement.

Case C-316/95.


Top of the page Documents in the Case
Document Date Name of the parties Subject-matter Curia EUR-Lex Autres Liens
Judgment
ECLI:EU:C:1997:347
09/07/1997 Generics v Smith Kline & French Laboratories
Judgment (Summary)
ECLI:EU:C:1997:347
09/07/1997 Generics v Smith Kline & French Laboratories
Opinion
ECLI:EU:C:1997:93
27/02/1997 Generics v Smith Kline & French Laboratories
Top of the page Legal analysis of the decision or of the case

Reports of Cases

1997 I-03929

Subject-matter

Preliminary ruling ─ Hoge Raad der Nederlanden ─ Interpretation of Articles 30 and 36 of the EC Treaty ─ Patent ─ National rule conferring on the proprietor of a pharmaceutical patent the right to oppose, during the currency of that patent, the submission by another person of samples to the authority responsible for the registration of medicinal products ─ Injunction against a counterfeiter prohibiting the marketing, after the expiry of the patent, of products which were protected by the patent during its currency

Systematic classification scheme

1.
B European Community (EEC/EC)
  B-02 Free movement of goods
    B-02.02 Prohibition of quantitative restrictions and measures having equivalent effect in trade between Member States
      B-02.02.03 Derogations
        B-02.02.03.04 Protection of industrial and commercial property
B European Community (EEC/EC)
  B-02 Free movement of goods
    B-02.02 Prohibition of quantitative restrictions and measures having equivalent effect in trade between Member States
      B-02.02.03 Derogations
        B-02.02.03.04 Protection of industrial and commercial property


Citations of case-law or legislation

References in grounds of judgment

Operative part

Opinion


Dates

Date of the lodging of the application initiating proceedings

  • 05/10/1995

Date of the Opinion

  • 27/02/1997

Date of the hearing

Information not available

Date of delivery

09/07/1997


References

Publication in the Official Journal

Application: OJ C 315 from 25.11.1995, p.12

Judgment: OJ C 271 from 06.09.1997, p.1

Name of the parties

Generics v Smith Kline & French Laboratories

Notes on Academic Writings

  1. Klauer, Irene: Registrierung eines patentierten Arzneimittels durch Dritte vor Ablauf der Patentfrist, St. Galler Europarechtsbriefe 1997 p.422-424
  2. Mok, M.R.: TVVS ondernemingsrecht en rechtspersonen 1997 p.257-258
  3. Rigaux, Anne: Europe 1997 Août-Sept. Comm. nº 270 p.10-11
  4. Lemaire, Olivier ; Strowel, Alain: La durée de protection des brevets de médicament, Revue de droit intellectuel : l'ingénieur-conseil 1997 p.389-401
  5. Botana Agra, M.: La violación de la patente en el procedimiento de autorización de comercialización del producto farmacéutico patentado. (Comentario a la sentencia del TJCE de 9 de julio de 1997, asunto C-316/95, Generics BV/Smith Kline & French Laboratories Ltd.), Actas de derecho industrial y derecho de autor 1997 Tomo XVIII p.265-282
  6. Dios, José María de: Jurisprudencia del Tribunal de Justicia de las Comunidades Europeas, Revista Jurídica de Catalunya 1998 p.597-599
  7. Galloux, Jean-Christophe: Recueil Dalloz Sirey 1999 Som. p.130-131



Procedural Analysis Information

Source of the question referred for a preliminary ruling

Hoge Raad der Nederlanden - Netherlands

Subject-matter

  • Free movement of goods
  • Approximation of laws
  • Intellectual, industrial and commercial property
  • - Patents

Provisions of national law referred to

Rijksoctrooiwet, art. 30, lid 3 Wet op de geneesmiddelenvoorziening, art. 29 Besluit registratie geneesmiddelen, art. 8, lid 1

Provisions of international law referred to

Information not available

Procedure and result

  • Reference for a preliminary ruling

Formation of the Court

Cour plénière (Cour)

Judge-Rapporteur

Gulmann

Advocate General

Jacobs

Language(s) of the Case

  • Dutch

Language(s) of the Opinion

  • English